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tice is also strongly discouraged in the rest of the EU according 
to Directive 2010/63/EU (EU, 2010) due to changes towards 
stricter regulation of experimental animal use. The bioassay 
used for testing of acute inhalation toxicity in the current study 
uses signs of potentially lethal lung damage observed during 
the experiment as an endpoint, rather than the death of the 
animal. Furthermore, acute toxicity caused by substance inha-
lation can have a very steep concentration-response curve, not 
least for the substances in the focus of this paper: impregnation 
products (IPs). 
The development of alternative methods for testing of chem-
ical toxicity has come a long way, but no alternative methods 
1  Introduction
Toxicity testing is traditionally performed in experimental ani-
mals for determination of toxic and non-toxic exposure levels. 
However, this practice is out of pace with current legislative 
and ethical developments. Much of the criticism is centered 
on the most common parameter used by authorities: the lethal 
concentration 50% (LC50), i.e., the concentration in inhaled 
air that is lethal to 50% of the animals. The LC50 uses death 
as the endpoint, an outcome that is associated with substantial 
suffering. For this reason, it is no longer permitted to test for 
the LC50 in Denmark (BEK no. 12 of 07/01/2016). The prac-
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Summary
Private consumers and professionals may experience acute inhalation toxicity after inhaling aerosolized impregnation 
products. The distinction between toxic and non-toxic products is difficult to make for producers and product users alike, 
as there is no clearly described relationship between the chemical composition of the products and induction of toxicity. 
The currently accepted method for determination of acute inhalation toxicity is based on experiments on animals; it is 
time-consuming, expensive and causes stress for the animals. Impregnation products are present on the market in large 
numbers and amounts and exhibit great variety. Therefore, an alternative method to screen for acute inhalation toxicity 
is needed. The aim of our study was to determine if inhibition of lung surfactant by impregnation products in vitro could 
accurately predict toxicity in vivo in mice. We tested 21 impregnation products using the constant flow through set-up of 
the constrained drop surfactometer to determine if the products inhibited surfactant function or not. The same products 
were tested in a mouse inhalation bioassay to determine their toxicity in vivo. The sensitivity was 100%, i.e., the in vitro 
method predicted all the products that were toxic for mice to inhale. The specificity of the in vitro test was 63%, i.e., the 
in vitro method found three false positives in the 21 tested products. Six of the products had been involved in accidental 
human inhalation where they caused acute inhalation toxicity. All of these six products inhibited lung surfactant function 
in vitro and were toxic to mice. 
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403 and 436 
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test for acute inhalation toxicity caused by IPs. An alternative 
method will firstly reduce the need for experimental animal 
testing by identifying potentially toxic products in vitro, al-
lowing for removal of toxic products before undertaking in 
vivo studies. Secondly, testing impregnation products in vitro 
will lead to better consumer safety by easing identification of 
potentially hazardous products before human health is jeopar-
dized. 
As the alternative method, we use the constant flow through 
set-up of the constrained drop surfactometer (cf-CDS) (Valle 
et al., 2015; Sørli et al., 2015a) as a screening tool to assess 
the effect of IPs on LS function. The cf-CDS method is a 
novel in vitro method that mimics the conditions for the LS 
in the lungs (Sørli et al., 2015a). A surfactant drop is placed 
on a hollow pedestal with a sharp edge, the volume (and so 
the surface area) is adjusted by introducing and removing liq-
uid through the base of the pedestal by a syringe connected 
to a computer-controlled stepping motor. This simulates the 
movement of the LS layer during breathing. Images of the 
drop are collected as it is cycled between the set minimum 
and maximum volume, and based on these images a computer 
program, ADSA (axisymmetric drop shape analysis) (Zuo et 
al., 2004; Saad and Neumann, 2016), calculates the surface 
tension of the drop continuously. To determine if the cf-CDS 
method can predict whether IPs are toxic to inhale, we ex-
posed mice to the same IPs by inhalation while continuously 
monitoring their respiration pattern to determine the effect on 
lung function in vivo. 
The mouse model used in the present study has previously 
been used to assess the airway irritation potential of industrial 
chemicals (Alarie, 1973; Nielsen et al., 2005). The effect of the 
test substance is assessed based on changes in the breathing 
pattern during respiration (Alarie, 1973). Inhalation of some 
aerosolized IPs leads to an irreversible reduction in tidal vol-
ume (Nørgaard et al., 2010, 2014; Duch et al., 2014; Sørli et 
al., 2015b). This effect has been proposed to be driven by in-
teraction between the IP and the LS, which may lead to devel-
opment of atelectasis (Nørgaard et al., 2010). Atelectasis may 
progress to tissue damage and edema, and product testing may 
therefore cause irreversible and lethal lung damage (Hubbs 
et al., 1997; Pauluhn et al., 2008; Nørgaard et al., 2010). We 
refined the mouse model during the course of the experiments 
to keep the potential suffering of the animals at the lowest 
possible level. The refinements are described in the section 
“Refinement of the in vivo model”.
Our aim was to determine whether LS inhibition could be 
used as an alternative method for testing acute inhalation 
toxicity of IPs. In the long run, this method may prove to 
be an alternative to the currently regulatory accepted OECD 
guidelines OECD TG 403 and 436 for acute inhalation toxicity 
using animals (OECD, 2009a,b). 21 IPs were tested using the 
cf-CDS method, whereof 6 have been involved in human in-
halation accidents. As 10 of the products had been previously 
been tested for acute inhalation toxicity in mice, only the other 
11 products were tested in the in vivo bioassay in the present 
study. The results from the in vitro method were subsequently 
compared to the in vivo toxicity in both mice and humans. 
exist for assessment of acute inhalation toxicity at present 
(Zuang et al., 2015). Any substance that reaches the deepest 
parts of the lung can potentially cause acute inhalation toxic-
ity, but the underlying mechanism is poorly understood and 
may vary depending on the characteristics of the substance. 
We have investigated the hypothesis that lung surfactant (LS) 
is a prime target in acute inhalation toxicity. LS covers the 
deepest parts of the lungs, i.e., the respiratory bronchioles and 
the alveoli, as a thin liquid film and is continuously formed 
and secreted by alveolar type II cells (Zuo et al., 2008). LS 
has several functions in the lungs, but the most important is 
to lower the surface tension at the air-liquid interface during 
respiration (Zuo et al., 2008). During breathing, the lungs are 
continuously exposed to the surrounding environment via the 
inhaled air, and the LS film is the first barrier that meets any 
inhaled substance. This interaction between substance and sur-
factant usually has little or no consequences for LS function, 
but some inhaled chemicals can disrupt the function of LS. 
This may lead to an increase in alveolar surface tension and 
subsequently alveolar collapse (Enhorning, 2001). Reopening 
of an atelectatic area requires energy, and breathing becomes 
labored. The friction, caused by the opening of the collapsed 
areas, may also cause damage to the airway epithelium, allow-
ing extravasation of blood and serum proteins into the lung 
lumen. These proteins inhibit LS function further (Ishizaka et 
al., 2004). 
IPs frequently cause acute inhalation toxicity in humans af-
ter accidental inhalation following application of the product. 
Instances where people have been injured after inhaling aero-
solized products are most often found as case reports in the 
literature (Fagan et al., 1977; Muller-Esch et al., 1982; Schicht 
et al., 1982; Okonek et al., 1983; Thibaut et al., 1983; Woo et 
al., 1983; Christensen et al., 1984; CDC, 1993a,b; Kelly and 
Ruffing, 1993; Laliberte et al., 1995; Yamashita and Tanaka, 
1995; Burkhart et al., 1996; Testud et al., 1998; Jacobsen et al., 
1999; Ota et al., 2000; Bonte et al., 2003; Malik and Chappell, 
2003; de Groot et al., 2004; Heinzer et al., 2004; Lazor-Blan-
chet et al., 2004; Tizzard and Edwards, 2004; Wallace and 
Brown, 2005; CDC, 2006; Vernez et al., 2006; Ebbehøj and 
Bang, 2008; Daubert et al., 2009; Hashimoto et al., 2009; 
Khalid et al., 2009; Epping et al., 2011; Fukui et al., 2011; 
Weibrecht and Rhyee, 2011; Duch et al., 2014; Nakazawa et 
al., 2014; Kikuchi et al., 2015; Bennett et al., 2015). These 
reports involve several different IPs and describe outbreaks in-
volving from one person to hundreds of people. The symptoms 
are similar for the different IPs; they develop quickly, in min-
utes to hours after exposure. The pulmonary symptoms include 
shortness of breath, coughing and tightness in the chest, but 
may also include systemic indicators such as headache, vom-
iting or fever. The symptoms usually spontaneously resolve 
within days of exposure, but may in some cases continue for an 
extended period of time (months after the inhalation incident) 
(Schicht et al., 1982; Burkhart et al., 1996; Ota et al., 2000; 
Wallace and Brown, 2005; Khalid et al., 2009; Fukui et al., 
2011; Kikuchi et al., 2015). 
The present study aimed to investigate whether disruption 
of LS function in vitro can be used as an alternative method to 
Sørli et al.
ALTEX 35(1), 2018 28
was reduced. Thus, IPs were tested with the lowest aerosoliza-
tion rate that caused inhibition within 5 min. All non-inhibiting 
IPs were tested for 10 min at the highest possible aerosoliza-
tion rate. After each experiment, the exposure was stopped 
and the chamber was left for 5 to 10 min to allow the volatile 
fraction of the IP to evaporate from the QCM and the deposited 
material to reach a stable plateau. 
A surface tension plot, where each dot corresponds to a single 
captured drop image, was created by ADSA. Representative 
surface tension profiles of LS subjected to inhibitory and non-in-
hibitory IPs can be found in Figure S11. Inhibition of LS activity 
was defined as at least seven consecutive minimum surface ten-
sions of ≥ 10 mN/m during compression. Atelectasis is thought 
to occur in vivo at this minimum surface tension (Tashiro et al., 
1998). Inhibition of LS function could, alternatively, be defined 
by an IP film forming on the drop (see below, Fig. 1).
Most of the inhibitory IPs inhibited the LS function by 
preventing the cycling LS from reaching a minimum surface 
tension below 10 mN/m. However, some products inhibited 
the LS function by forming a thick film on the surface of the 
surfactant droplet during dynamic cycling. The IP film held 
together the droplet and increased the surface viscosity, thus 
resulting in the top of the droplet being “flattened” during 
compression (Fig. 1). The thickness of the IP film seemed to 
gradually increase with time. For the products “Stain repel-
lent nano” and “Liquid stain protection”, the LS was inhibited 
as a low surface tension could not be reached (the minimum 
surface tension increased to > 10 mN/m after 9 and 30 s of ex-
posure, respectively). In addition, a film appeared 3 and 10 min 
after the start of exposure, respectively. For “HG textile” and 
“HG leather” the minimum surface tension did not increase to 
levels above 10 mN/m, however a film formed on the LS drop 
after less than 2 min of exposure. The “flattened” images are 
analyzed as having a low surface tension by ADSA, but with 
continuous cycling the IP film distorted the axisymmetry of the 
drop by wrinkling the surface or skewing the drop. The latter 
images cannot be analyzed by ADSA and it gives a warning. 
2  Animals, materials and methods
Generation of IP aerosols
Aerosols of the tested IPs were generated in the same way for in 
vitro and in vivo experiments. The product was led from a glass 
syringe into a Pitt no. 1 jet nebulizer (Wong and Alarie, 1982) 
by an infusion pump (New England Medical Instruments Inc., 
Medway, MA, USA). In the in vitro experiments, the exposure 
air-stream was led through glass columns and into the 1.9-l 
chamber of the cf-CDS and sucked out through the baseplate. 
For the in vivo mouse bioassay, the IP aerosols entered a 20-l 
exposure chamber of glass and stainless steel (Clausen et al., 
2003), with an air exchange rate of approximately 1 per min. 
Outlet air was passed through a series of particle and active 
coal filters before exhaust to the atmosphere. 
In vitro method measuring LS inhibition
LS inhibition in vitro was tested using the cf-CDS method 
(Sørli et al., 2015a) by exposing a drop of LS to increasing 
amounts of IP. A drop of LS (Curosurf®, 10 μl of 2.5 mg/ml) 
was placed on a hollow based pedestal with a sharp edge, and 
subjected to dynamic cycling at 40 cycles/min and less than 
30% compression. The cf-CDS and aerosol generation setup 
was kept at 37°C inside a heating box. In short, a steady stream 
of air (containing the aerosolized IP) flowed from the top to 
bottom of the chamber to expose the LS to an increasing con-
centration of the tested product. The exposure concentration 
was monitored by a quartz crystal microbalance (QCM) placed 
close to the pedestal. 
The LS was cycled prior to exposure to obtain a baseline 
value for the surface tension, and any experiment with a mini-
mum surface tension of > 5 mN/m was discarded. The cycling 
of the LS was stopped at intervals and the drop was refilled 
with buffer to replace liquid that had evaporated. Images were 
continuously taken of the drop and analyzed by ADSA. The 
primary output was the surface tension of the LS drop. If the IP 
inhibited the LS (as described below), the aerosolization rate 
Fig. 1: Images of the surfactant drop with IP film formation during compression
An LS drop not exposed to IP (left) has a rounded shape. When an IP film forms on the surfactant drop, the top is “flattened”. LS drop 
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behind a specific pathogen free (SPF) barrier. Thus, 212 inbred 
BALB/cJ male mice aged 5-8 weeks at arrival were purchased 
from Taconic M&B (Ry, Denmark) and housed in polypropyl-
ene cages (1290D Eurostandard type III from Scanbur, 425 x 
266 x 155 mm) furnished with aspen bedding material (Tapvei, 
Estonia), enriched with a mouse house (80-ACRE011, Tech-
niplast, Italy) and small aspen blocks (Tapvei, Estonia). The 
mice were 6-12 weeks old when they were used in the bioassay. 
The photo-period was from 06:00 to 18:00, the temperature 
21°C and relative humidity 55%. Cages were sanitized twice 
weekly. Food (Altromin no. 1324, Altromin, Lage, Germany) 
and municipal tap water were available ad libitum. The mice 
The warning, combined with visual confirmation of the “flat-
tening” of the drop, defined the products as inhibitory to LS. If 
the IP film “only” flattened the drop, the determination had to 
be done visually. The drop image is followed visually through-
out the experiment, and the flattening is clearly noticeable. 
Animals
The mouse bioassay data for 10 of the IPs have been published 
previously (see Tab. 1). For the 11 additional IP bioassays, 
mice were of a similar strain (BALB/cJ, as the BALB/cA strain 
is no longer available) and age as in previous experiments and 
were housed under the same conditions. The mice were kept 
Tab. 1: The source of the 21 impregnation products used in this study and references to previously published  
in vivo mouse bioassay data and known human toxicity
Impregnation product Source  In vivo data published Human toxicity
“Wood impregnation”  Dr Scheepers, Radboud University Yes (Sørli et al., 2015b) Yes (Scheepers et al., 2016) 
 Nijmegen (The Netherlands)
“Stain repellent super” Akemi GmbH (Nürnberg, Germany) Yes (Duch et al., 2014) Yes (Duch et al., 2014)
“Liquid stain protection”  Dorothee Walter, Fraunhofer ITEM  Yes (Hahn et al., 2015) 
 (Hannover, Germany)
“Faceal oleo MG” PSS Interservice  Yes (personal communication,  
 (Geroldswil, Switzerland)  Danish poison center)
“HG textile”a  HG International  Yes (personal communication,  
 (Almere, The Netherlands)  Dutch poison center)
“HG leather”a HG International  Yes (personal communication,  
 (Almere, The Netherlands)  Dutch poison center)
“Antismuds”  ENC Natursten A/S  
 (Svendborg, Denmark)  
“Footwear protector”  Granger’s (Derbyshire, UK) Yes (Sørli et al., 2015b)
“Nakano impregnation”  Harald Nyborg (Odense, Denmark)  
“Non-absorbing floor  NanoCover (Aalborg, Denmark) Yes (Nørgaard et al., 2010) 
materials”
“Rim sealer”  NanoLotus (Odense, Denmark) Yes (Sørli et al., 2015b)
“Stain repellent nano” Akemi GmbH (Nürnberg, Germany)  
“Stain repellent”  Akemi GmbH (Nürnberg, Germany)  
“Bath and tiles”  NanoCover (Aalborg, Denmark) Yes (Nørgaard et al., 2010)
“Faceal oleo HD” PSS Interservice (Geroldswil,  
 Switzerland)  
“Special textile coating”  NanoLotus (Odense, Denmark) Yes (Nørgaard et al., 2014)
“Textiles and leather  NanoCover (Aalborg, Denmark) Yes (Nørgaard et al., 2014) 
concentrate” 
“Textiles and leather”  NanoCover (Aalborg, Denmark) Yes (Sørli et al., 2015b)
“Car glass” NanoCover (Aalborg, Denmark) Yes (Sørli et al., 2015b)
“Footwear repel” Granger’s (Derbyshire, UK)  
“Performance repel”  Granger’s (Derbyshire, UK)  
a full names “HG water, oil, fat & dirt proof for textile” and “HG water, oil, fat & dirt proof for leather”, respectively
Sørli et al.
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a high starting concentration, and then decreasing the concen-
tration used to expose other groups of mice until no effect on 
the VT was seen. For the IP “Liquid stain protection”, groups 
of 8-10 mice were subjected to a high starting concentration, 
followed by lower concentrations, but the NOAEC was de-
termined after doing a range-finding experiment, followed by 
a NOAEC experiment (see below). For the remaining seven 
IPs the following was done: an initial range-finding experi-
ment was performed by exposing a group of mice (n = 4-5) 
to increasing concentrations of IP. The start concentration was 
set based on data from the cf-CDS method, i.e., an IP that 
inhibited LS function started at a lower concentration than 
a product that did not inhibit LS in vitro. This was done to 
ensure that the first concentration would not cause acute inha-
lation toxicity. Following recording of the baseline, the start 
concentration was used during the first 15 min of exposure, 
and if no effect was observed at the previous concentration 
the infusion flowrate was then doubled every 15 min. If no 
effect was observed after a total of 60 min exposure (and 
testing of four concentrations), a second range-finding ex-
periment was done using a new group of mice and the flow 
rate was increased until the highest concentration that could 
be generated in the system was reached. If no effect occurred 
during any of the range-finding experiments, a group of mice 
(n = 5-7) was exposed to the highest concentration that could be 
generated and this concentration was designated the NOAEC. 
If, on the other hand, an effect occurred in the range-finding 
experiment, a group of mice (n = 5-7) was subjected for 60 
min to the concentration previous (lower) to the one causing 
the effect in the range-finding experiment. If no reduction in 
VT was observed during this experiment, this concentration 
was denoted the NOAEC. However, if an effect did occur 
during the 60-min period, the concentration was reduced again 
by half and this exposure concentration was generated for 
60 min as described above.
Refinement of the in vivo model 
We have worked with the acute airway effect of IPs for several 
years (Nørgaard et al., 2010, 2014; Duch et al., 2014; Sørli et 
al., 2015b), and during this period, the in vivo bioassay has 
gone through several rounds of refinement.
From the first sets of experiments (Nørgaard et al., 2010, 
2014), we know that the toxic response to IPs is very uniform, 
and manifests as a rapid reduction in VT. Animals experienc-
ing a toxic response to an IP are in a moribund state and will 
die within 24 h (Nørgaard et al., 2010). The reduction of VT 
is irreversible and recovery does not occur (Nørgaard et al., 
2010, 2014; Duch et al., 2014; Sørli et al., 2015b). A severe 
reduction in VT during the experiment (> 50% reduction com-
pared to baseline) can lead to death during exposure (Nørgaard 
et al., 2010, 2014; Duch et al., 2014; Sørli et al., 2015b). Based 
on these observations, we reduced the group size in each ex-
periment from n = 10 to n = 4-5 during range-finding, and to n 
= 5-7 for determination of the NOAEC. The animals were re-
moved after the experiment and killed immediately by cervical 
dislocation without a period of recovery to reduce the time a 
single animal was exposed and restrained. In addition, animals 
were randomly assigned to cages upon arrival, 3-4 mice per 
cage, and acclimatized for a minimum of one week. Generally, 
mice from the same cage were used in the same experiment; 
the mice had not been used for any other procedures prior to 
the bioassay. The experiments were performed between 09:00 
and 15:00. The breathing pattern of each mouse was monitored 
in real time and the mice were visually monitored throughout 
the experiment. 
Ethical statement
Treatment of the animals followed procedures approved by the 
Animal Experiment Inspectorate, Denmark (Permissions No. 
2006/561-1123-C3, 2012−15−2934−00616-C1 and 2014-15-
2934-01042-C2). All experiments were performed by trained 
personnel and conformed to the Danish Regulations on Animal 
Experiments (LBK nr. 474 af 15/05/2014 and BEK nr 1589 
af 11/12/2015), which include guidelines on care and use of 
animals in research. Anesthesia was not used during the ex-
periments, because the bioassay depends on the animals being 
fully awake with uncompromised breathing. Acute inhalation 
toxicity was observed as a rapid depression of the tidal vol-
ume. The mouse bioassay has gone through several rounds of 
refinement as described below. The number of animals used to 
test the toxicity of each product is given in Table S11.
Collection of respiratory parameters 
The Notocord Hem (Notocord Systems SA, Croissy-sur-Seine, 
France) data acquisition software was used to collect and cal-
culate several mouse respiratory parameters. We used the tidal 
volume (VT, mL) and respiratory frequency (breaths/min), but 
the program also calculates parameters linked to airway irrita-
tion and other parameters not reported in this study. Atelectasis 
may be observed as an irreversible decrease in VT, concur-
rent with a compensatory increase in respiratory frequency 
(Nørgaard et al., 2010, 2014). Comprehensive descriptions of 
the breathing parameters and their interpretation have been 
made elsewhere (Alarie, 1973; Vijayaraghavan et al., 1993; 
Larsen and Nielsen, 2000). Data acquisition and calculations 
were performed as described previously (Larsen et al., 2004).
Mouse bioassay for evaluation of acute inhalation toxicity
To assess the acute effects of IPs on respiration, groups of 
mice (n = 4-10, see Tab. S11) were placed in individual, whole 
body plethysmographs and exposed head-out. First, a 15-min 
baseline period was recorded for each mouse while inhaling 
laboratory air. Then, the mice were exposed to the IP until the 
breathing pattern was affected, or for a maximum of 60 min. 
To assess exposure-related effects, the respiratory parameters 
during exposure were compared in real time to baseline levels, 
i.e., each mouse served as its own control. For each mouse, 
mean values of each minute during the experiment were cal-
culated. Examples of concentration- and time-dependent effect 
curves can be found in (Nørgaard et al., 2010, 2014; Duch et 
al., 2014; Sørli et al., 2015b)
For the products “Stain repellent”, “Stain repellent nano” 
and “Antismuds”, the No Observed Adverse Effect Concentra-
tion (NOAEC) was found by exposing a group of 8-10 mice to 
Sørli et al.
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4) The “Wood impregnation” product was involved in an in-
halation toxicity accident involving 10 workers. One liter of 
the product was sprayed in a workshop, and one person who 
entered the workshop shortly after the application rapidly 
developed respiratory symptoms and was diagnosed with 
severe chemical pneumonitis. Nine people, working in the 
room next door, who were exposed 15 hours after the spray-
ing incidence, experienced dry cough and chest tightness 
(Scheepers et al., 2016).
5) The “Liquid stain protection” product caused 11 described 
cases of intoxication between 2003 and 2011 that were 
related to application of the product. Symptoms ranged in 
severity from minor to severe, but all cases presented with 
initial severe cough (Hahn et al., 2015). 
6) The product “Stain Repellent Super” was the cause of a 
large inhalation exposure accident in Greenland when the 
IP was sprayed on the ground floor of a supermarket using 
an airless spray gun. In the hours following the application, 
43 people contacted the local hospital with respiratory 
symptoms, and 39 thereof were clinically examined. Their 
symptoms included coughing, tachypnoea, chest pain, gen-
eral malaise and fever. The physical examination revealed 
perihilar lung infiltrates on chest radiographs and reduced 
blood oxygen saturation. The acute symptoms resolved 
gradually within 1-3 days and no delayed symptoms were 
observed. The incident is described in detail by Duch et al. 
(2014).
3  Results
3.1  Lung surfactant inhibition in vitro
21 IPs were tested in the cf-CDS method. Five IPs had no inhib-
itory effect, whereas 16 products inhibited LS function (Tab. 2). 
3.2  In vivo toxicity in mice
The NOAEC of 10 of the IPs had been determined in the mouse 
bioassay previously (see Tab. 1), thus for this work, only the 
other 11 IPs were tested. NOAEC was determined in vivo and 
defined as the highest concentration at which there was no 
change in VT compared to baseline. Of the total of 21 products, 
8 did not affect VT, even at the highest exposure concentration 
that could be generated (Tab. 2). 
 
3.3  Correlation of in vitro, in vivo,  
and human data
The effect of IPs on LS function in vitro is summarized in Table 
2, alongside their in vivo effects in mice and their involvement 
in human toxicity accidents, if any. Overall there is correlation 
between classification of a product as inhibitory or not in vitro 
and the presence or absence of toxicity to mice for 18 of the 
21 IPs. Importantly, all 13 products that were toxic to mice 
also inhibited LS in vitro. Thus, the sensitivity (true positive 
rate) of the in vitro method is 100%. There were no false neg-
atives, i.e., no products that were toxic to mice were classified 
as “not inhibitory” to LS. Of the 8 products that were non-toxic 
to mice, only 5 did not inhibit LS function in vitro, therefore 
with a rapid reduction in VT were removed from the exposure 
chamber and killed immediately. Finally, data from the cf-CDS 
method was used to determine the start concentration in the 
range-finding experiment, so that exposure to products inhibit-
ing LS in vitro started at a lower concentration and accidental 
induction of acute inhalation effects was prevented. 
Exposure monitoring
Exposure concentrations in the bioassay were calculated by 
gravimetric filter sampling (described in Clausen et al., 2003) 
combined with measurement of the non-volatile compounds 
of the products to calculate the wet weight of the product ex-
posure. To determine the non-volatile fraction of the products, 
approximately 1 ml of test IP was transferred to a pre-weighed 
2 ml glass vial and purged to dryness at ambient temperature 
by a gentle stream of nitrogen. The non-volatile fraction was 
determined gravimetrically in duplicate. Aerosol particle size 
distribution was measured for the 10 previously published bio-
assays (Nørgaard et al., 2010; Duch et al., 2014; Sørli et al., 
2015b) (Tab. S21). These IPs contain a variety of solvents and 
active ingredients, and aerosolization consistently produced 
inhalable droplets. The same aerosolization technique was 
used in the present publication. We therefore assumed that the 
additional products tested for this publication also produced 
respirable droplets. 
Human toxicity
Six of the tested products have accidently been inhaled by and 
associated with toxicity in humans. 
1) The product “HG leather” had been used in an unventilated 
room and the woman who had used the product felt like she 
was going to faint, but there were no respiratory complaints 
at the time of the emergency call. Information on this case 
was provided by the Dutch poison center.
2) The product “HG textile” was involved in two poisoning 
cases. In the first case, a woman complained of dyspnea, 
cough, dizziness, tiredness and myalgia the day after us-
ing the product. On examination, there were no signs of 
pneumonia or fever, and her oxygen saturation was normal. 
In the second case, a woman had sprayed two whole cans 
(2 x 300 ml) of the product and two days later complained 
of headache, dyspnea and cough. Upon examination, she 
did not have a fever and her oxygen saturation was 97%. 
Information on these cases was provided by the Dutch poi-
son center.
3) A worker sprayed 10-15 l of the product “Faceal Oleo MG” 
on a tile surface using a low-pressure spraying device; the 
application took approximately 30 min. The location, a 
staircase leading down to a metro station, was partly open 
to ambient air, but without active ventilation. The person 
did not wear respiratory protection during the application. 
The worker started coughing 20 min after the spraying, 
developed chills and was taken to hospital where he pre-
sented with slightly decreased O2 saturation. The symptoms 
resolved after 24 h, but the patient subsequently developed 
non-allergic asthma (personal communication, Danish poi-
son center). 
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compounds are found both in toxic and non-toxic products (e.g., 
“Rim sealer” and “Textiles and leather”, respectively, see Tab. 
S21). A strategy to make products safe has been to use water as 
a solvent, however, “Footwear protector” is toxic whereas “Per-
formance repel” is not – though both are water-based (Tab. S21). 
To complicate matters further, it has previously been shown that 
different solvents may modify the toxicity of an active ingredi-
ent – or may even be a prerequisite for its toxicity (Nørgaard et 
al., 2014). Thus, the toxicity of a particular IP is hard to predict, 
and several different chemical compositions can induce a toxic 
response. Our current knowledge does not allow prediction of 
inhalation toxicity of an IP based on its chemical composition. 
Safety testing of all possible combinations of substances by the 
conventional in vivo bioassay is not a rational option. Regula-
tion of specific products is further hampered by the name of the 
toxic product often being omitted in case reports. Even when 
the product name is given, this does not grant access to the 
complete chemical composition as Material Safety Data Sheets 
are often incomplete. Finding a good predictor of the acute and 
serious lung reaction will ease the identification of hazardous 
products both during product development and upon suspicion 
of toxicity of specific products. 
the specificity (true negative rate) of the cf-CDS method was 
5/8 = 63%. In other words, the false positive rate in vitro, i.e., 
the likelihood of labeling a product as toxic in vitro when it 
would not have an effect in vivo, is 37%. In humans, 6 of the 
21 investigated IPs have given rise to cases of acute inhalation 
toxicity. All of these 6 products also caused in vivo toxicity in 
mice and inhibition of LS in vitro.
4  Discussion
Impregnation products consist of very complex chemical mix-
tures. They contain active ingredients, which form a water and 
dirt repellent surface film after application, solvents that carry 
the active ingredient, and in some cases also a propellant. Each 
product may contain several different substances from each of 
these categories. The cause of the observed toxicity of IPs has 
been suggested to relate to the overall chemical composition of 
the products, rather than to individual chemicals (Nørgaard et 
al., 2014). We and other researchers have not been able to iden-
tify a clear relationship between the content of specific groups 
of chemicals and the toxicity of IPs. As an example, fluorinated 
Tab. 2: Summary of the effect of impregnation products on LS function in vitro, on the breathing pattern of mice, correlation 
between in vitro and in vivo results, and involvement in human acute inhalation toxicity accidents 
Impregnation product In vitro LS inhibition  In vivo toxicity Correlation in vitro – in vivo Human toxicity
“Wood impregnation”  Yes Yes Yes Yes
“Stain repellent super” Yes Yes Yes Yes
“Liquid stain protection”  Yes Yes Yes Yes
“Faceal oleo MG” Yes Yes Yes Yes
“HG textile”  Yes Yes Yes Yes
“HG leather” Yes Yes Yes Yes
“Antismuds”  Yes Yes Yes – 
“Footwear protector”  Yes Yes Yes –
“Nakano impregnation”  Yes Yes Yes –
“Non-absorbing floor materials”  Yes Yes Yes –
“Rim sealer”  Yes Yes Yes –
“Stain repellent nano”  Yes Yes Yes –
“Stain repellent”  Yes Yes Yes –
“Bath and tiles”  No No Yes –
“Faceal oleo HD” No No Yes –
“Special textile coating”  No No Yes –
“Textiles and leather concentrate”  No No Yes –
“Textiles and leather”  No No Yes –
“Car glass”  Yes No No, false positive –
“Footwear repel”  Yes No No, false positive –
“Performance repel”  Yes No No, false positive –
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surfactometer (Sørli et al., 2015b)) was limited to the study 
of water soluble products. The cf-CDS method is much more 
suitable for testing the interaction of chemicals with the LS, as 
the method mimics the physiological conditions of the lung, 
such as cycling frequency, the extent of the compression, and 
temperature. The cf-CDS method can test products of any 
composition, the exposure concentration can be continuously 
increased, and the exposure concentration can be monitored 
(Sørli et al., 2015a). 
Of the 21 products tested, 13 were toxic to mice, and also 
inhibited LS function in vitro. It is however not possible to 
use the in vitro ranking to predict the NOAEC exposure con-
centration in vivo. There are several reasons for this, but one 
important factor is the difference in exposure concentration 
measurement. For the mouse bioassay, the concentration is 
calculated by combining filter measurements of the exposure 
atmosphere and the dry weight of the non-volatile fraction af-
ter drying with nitrogen. For the cf-CDS method, the concen-
tration is calculated as the non-volatile fraction of the IP that 
settles on the QCM and has not evaporated after drying for 
5 min under a stream of air. Depending on whether an IP is 
dried under a flow of nitrogen, a flow of air in the animal 
exposure chamber, or in the CDS chamber, the drying is dif-
ferent; therefore, the measured exposure concentrations are 
not directly comparable. Instead, the in vitro method can be 
used as a qualitative toxic/non-toxic screening method prior 
to or instead of the mouse bioassay. As we develop the cf-
CDS method further, we will try to make more comparable 
measurements of exposure concentration, e.g., by measuring 
the aerosol composition in both chambers. 
The concentration of LS used in the in vitro assay (2.5 mg/
ml) is lower than the concentration in the lung lining fluid. 
The surfactant concentration in the alveolar hypophase is esti-
mated to range from 30 to 100 mg/ml, depending on the spe-
cific mammalian species (Zuo et al., 2008). However, we and 
others have found the same equilibrium, minimum and max-
imum surface tension of a range of surfactant concentrations 
(0.5 to 28 mg/ml), surfactant preparations (Infasurf, BLES 
and Curosurf®) and method of analysis (pulsating bubble sur-
factometer, captive bubble surfactometer or CDS) (Bachofen 
et al., 2005; Acosta et al., 2007; Zuo et al., 2008; Valle et al., 
2014, 2015). If the existing guideline for measuring acute 
inhalation toxicity using animals is going to be replaced, the 
replacement has to be cheap and easy to perform. Using 2.5 
mg/ml as the test concentration in the in vitro method is a 
good approximation to the lungs when measured according to 
the surface tension. 
The relatively high false positive rate (the in vitro method 
predicted 37% of the non-toxic IPs as toxic) may be a draw-
back of the method. However, if the positive products are test-
ed in animals for confirmation, there is a high risk of testing 
toxic products and causing suffering to the animals.
Based on the knowledge of the current project and earlier 
work (Sørli et al., 2015a), we would recommend that potential 
products first be tested in vitro and that the results from this 
test will determine the progression to animal testing. Products 
IPs may cause acute inhalation toxicity to consumers and 
the effects of the inhalation can be moderate to severe. In 
this paper, we describe an in vitro method that can be used to 
screen for toxicity of IPs. The method detected all the products 
that were toxic to mice upon inhalation. More importantly, all 
products that have been associated with inhalation toxicity in 
humans were detected in the in vitro model. The method has 
proven useful for determining the inhalation toxicity of IPs, 
however we do not know if it can be used with the same suc-
cess with other chemical classes. We will continue the work 
with other substances to determine if the method can be used to 
predict the inhalation toxicity of other inhaled substances. As 
part of developing the cf-CDS method, we tested commercially 
available pharmaceutical formulations intended for inhalation 
(Sørli et al., 2015a). These formulations have proven to be safe 
for humans to inhale, and we found no effect on LS function, 
even at extreme concentrations. This and testing the method 
with IPs are the first steps in the process towards establishing 
an alternative method to acute inhalation toxicity testing in an-
imals, i.e., OECD TG 403 or 436 (OECD, 2009a,b). 
The cf-CDS method only screens for acute inhalation 
toxicity related to disruption of LS function. There may be 
other mechanisms associated with inhalation toxicity that are 
not related to LS inhibition, such as cytotoxicity or systemic 
toxicity; these mechanisms would not be picked up by the 
LS inhibition method. This has to be taken into consideration 
before the assay can be accepted by regulators. Addition of 
an in vitro method that can measure cytotoxicity and systemic 
toxicity may be required before the current guidelines (OECD, 
2009a,b) can be completely replaced. 
The cf-CDS method did not falsely identify acutely toxic 
products as safe, i.e., no false negative results were observed. 
The cf-CDS method did however identify some products as 
toxic even if no reaction was observed in the mouse bioassay 
(false positives). Curosurf®, the LS used in the in vitro tests, 
does not contain all the components found in natural lung sur-
factant, such as the proteins SP-A and SP-C and cholesterol. 
This difference may make the surfactant more sensitive to inhi-
bition, and may be the reason for the false positives predicted 
by the in vitro method. However, even if natural surfactant may 
be a better approximation to lung function in vivo, it is diffi-
cult to obtain in sufficient and reliable amounts. An alternative 
method to the existing OECD guidelines using animals cannot 
rely on laborious collection of surfactant, when there are com-
mercially, well characterized and controlled LS preparations 
readily available. We have therefore chosen to base the cf-CDS 
method on this commercial LS preparation. 
We have previously shown that when IPs were tested in 
other in vitro models of LS inhibition (in the Langmuir trough 
or using the Capillary surfactometer), the results correlat-
ed well with inhalation toxicity in mice (Duch et al., 2014; 
Sørli et al., 2015b). However, neither method could mimic 
physiologically relevant conditions, such as the frequency 
of cycling between the maximum and minimum surface area 
of the LS film and manipulation of the atmosphere that the 
LS film was exposed to. One of the methods (the Capillary 
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screening tool for aerosol products. XXXV International 
Congress of the European Association of Poisons Centres and 
Clinical Toxicologists. Clin Toxicol 53, 318-318. doi:10.3109
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Hashimoto, K., Arita, K., Kajihara, T. et al. (2009). Two cases 
of lung injury due to inhalation of waterproofing spray – With 
that inhibit LS function should be discarded or reformulated 
before a new in vitro test is performed. IPs that do not inhibit 
LS function will still need to be tested in animals at the mo-
ment. However, as the method is tested with more potentially 
inhaled substances, we believe that the cf-CDS, possibly in 
combination with other in vitro assays, will be able to com-
pletely replace the currently accepted acute inhalation toxicity 
test. Using this approach will reduce the suffering that would 
otherwise have occurred during testing of toxic products, and 
will reduce the number of animals needed for testing. 
Six of the tested products have been involved in incidents in 
which up to 43 people were exposed to aerosols of the product 
and subsequently fell ill. Human acute inhalation toxicity of-
ten occurs when consumers do not use the product as intended 
by the manufacturer, e.g., by spraying a product that should 
be applied with a mop or brush, or using a nozzle producing 
small droplets (case number 6 and 3, respectively). However, 
in some of the inhalation toxicity cases, the products were in-
tended for spraying (e.g., case 1 and 2). 
In summary, testing whether an impregnation product caus-
es inhibition of lung surfactant in vitro is an excellent way of 
screening products before they are marketed and potentially 
can cause harm to humans. The cf-CDS method is a promising 
model for such screening.
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